A new way cancer cells can die, still in early lab study
Original title: Disulfidptosis: From metabolic vulnerability to precision therapy - Molecular mechanisms, disease spectrum, and translational challenges.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a review of early lab work, not a new result or a treatment people can get.
The short version
Scientists are studying a new way to make cancer cells die, but it has not been tested in people yet.
What was studied. This is a review paper. The authors gathered lab research on a new form of cell death called disulfidptosis.
What they found. Some cancer cells make a lot of a protein called SLC7A11. When those cells run low on sugar, they pull in too much of a building block called cystine. The stress tangles the cell's inner frame and the cell breaks open. The authors say lab work points to this idea in glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary and several other cancers.
What this means, and what it doesn't
What it could mean: Nothing changes in care today. It points to a possible target for future drugs, including ones for brain tumors. The authors also list big problems to solve first, like hitting only the tumor, safety, and getting a drug to the right cells.
What it doesn't mean: This is not a treatment and not a cure. It is a review of early lab work, not a study in people. The authors say human testing has not happened yet. There is no way to get this today, and it is far from everyday care.
Source: PubMed, November 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.